These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 18585350

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of the CALHM1 G330D and R154H human variants on the control of cytosolic Ca2+ and Aβ levels.
    Vingtdeux V, Tanis JE, Chandakkar P, Zhao H, Dreses-Werringloer U, Campagne F, Foskett JK, Marambaud P.
    PLoS One; 2014; 9(11):e112484. PubMed ID: 25386646
    [Abstract] [Full Text] [Related]

  • 8. CALHM1 polymorphism is not associated with late-onset Alzheimer disease.
    Beecham GW, Schnetz-Boutaud N, Haines JL, Pericak-Vance MA.
    Ann Hum Genet; 2009 May; 73(Pt 3):379-81. PubMed ID: 19472444
    [Abstract] [Full Text] [Related]

  • 9. Genetic association of CALHM1 rs2986017 polymorphism with risk of Alzheimer's disease: a meta-analysis.
    Lu Y, Liu W, Tan K, Peng J, Zhu Y, Wang X.
    Neurol Sci; 2016 Apr; 37(4):525-32. PubMed ID: 26700797
    [Abstract] [Full Text] [Related]

  • 10. CALHM1 P86L polymorphism is a risk factor for Alzheimer's disease in the Chinese population.
    Cui PJ, Zheng L, Cao L, Wang Y, Deng YL, Wang G, Xu W, Tang HD, Ma JF, Zhang T, Ding JQ, Cheng Q, Chen SD.
    J Alzheimers Dis; 2010 Apr; 19(1):31-5. PubMed ID: 20061624
    [Abstract] [Full Text] [Related]

  • 11. No association between CALHM1 and risk for Alzheimer dementia in a Belgian population.
    Sleegers K, Brouwers N, Bettens K, Engelborghs S, van Miegroet H, De Deyn PP, Van Broeckhoven C.
    Hum Mutat; 2009 Apr; 30(4):E570-4. PubMed ID: 19191332
    [Abstract] [Full Text] [Related]

  • 12. The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study.
    Lambert JC, Sleegers K, González-Pérez A, Ingelsson M, Beecham GW, Hiltunen M, Combarros O, Bullido MJ, Brouwers N, Bettens K, Berr C, Pasquier F, Richard F, Dekosky ST, Hannequin D, Haines JL, Tognoni G, Fiévet N, Dartigues JF, Tzourio C, Engelborghs S, Arosio B, Coto E, De Deyn P, Del Zompo M, Mateo I, Boada M, Antunez C, Lopez-Arrieta J, Epelbaum J, Schjeide BM, Frank-Garcia A, Giedraitis V, Helisalmi S, Porcellini E, Pilotto A, Forti P, Ferri R, Delepine M, Zelenika D, Lathrop M, Scarpini E, Siciliano G, Solfrizzi V, Sorbi S, Spalletta G, Ravaglia G, Valdivieso F, Vepsäläinen S, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossù P, Hanon O, Piccardi P, Annoni G, Mann D, Marambaud P, Seripa D, Galimberti D, Tanzi RE, Bertram L, Lendon C, Lannfelt L, Licastro F, Campion D, Pericak-Vance MA, Soininen H, Van Broeckhoven C, Alpérovitch A, Ruiz A, Kamboh MI, Amouyel P.
    J Alzheimers Dis; 2010 Apr; 22(1):247-55. PubMed ID: 20847397
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CALHM1 ion channel elicits amyloid-β clearance by insulin-degrading enzyme in cell lines and in vivo in the mouse brain.
    Vingtdeux V, Chandakkar P, Zhao H, Blanc L, Ruiz S, Marambaud P.
    J Cell Sci; 2015 Jul 01; 128(13):2330-8. PubMed ID: 25999473
    [Abstract] [Full Text] [Related]

  • 16. CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model.
    Boada M, Antúnez C, López-Arrieta J, Galán JJ, Morón FJ, Hernández I, Marín J, Martínez-Lage P, Alegret M, Carrasco JM, Moreno C, Real LM, González-Pérez A, Tárraga L, Ruiz A.
    J Alzheimers Dis; 2010 Jul 01; 20(1):247-51. PubMed ID: 20164592
    [Abstract] [Full Text] [Related]

  • 17. Lack of implication for CALHM1 P86L common variation in Italian patients with early and late onset Alzheimer's disease.
    Nacmias B, Tedde A, Bagnoli S, Lucenteforte E, Cellini E, Piaceri I, Guarnieri BM, Bessi V, Bracco L, Sorbi S.
    J Alzheimers Dis; 2010 Jul 01; 20(1):37-41. PubMed ID: 20164602
    [Abstract] [Full Text] [Related]

  • 18. CALHM1 controls the Ca²⁺-dependent MEK, ERK, RSK and MSK signaling cascade in neurons.
    Dreses-Werringloer U, Vingtdeux V, Zhao H, Chandakkar P, Davies P, Marambaud P.
    J Cell Sci; 2013 Mar 01; 126(Pt 5):1199-206. PubMed ID: 23345406
    [Abstract] [Full Text] [Related]

  • 19. A polymorphism in CALHM1 is associated with temporal lobe epilepsy.
    Lv RJ, He JS, Fu YH, Shao XQ, Wu LW, Lu Q, Jin LR, Liu H.
    Epilepsy Behav; 2011 Apr 01; 20(4):681-5. PubMed ID: 21439911
    [Abstract] [Full Text] [Related]

  • 20. No association between CALHM1 polymorphism and Alzheimer's disease risk in a Hungarian population.
    Fehér A, Juhász A, Rimanóczy A, Pákáski M, Kálmán J, Janka Z.
    Psychiatr Genet; 2011 Oct 01; 21(5):249-52. PubMed ID: 21378601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.